Overview

Treatment of Aggressive Localized Lymphoma

Status:
Terminated

Trial end date:
2017-02-01

Target enrollment:

Participant gender:

Summary

Prospective and multicentric Phase III study, evaluation of the interest of the radiotherapy after 4 or 6 cycles of CHOP 14 R regimen of chemotherapy , patients with agressive and localized B lymphoma , age 18 to 75 years.

Phase:

Phase 3

Details

Lead Sponsor:

French Innovative Leukemia Organisation

Treatments:

Doxorubicin
Liposomal doxorubicin
Prednisone
Rituximab
Vincristine